VIGL
USDVigil Neuroscience Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$7.870
Máximo
$7.880
Mínimo
$7.840
Volumen
3.58M
Fundamentos de la Empresa
Capitalización de Mercado
367.3M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
1.10M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm
The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Vigil Neuroscience, Inc. ...
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, AXL, SWTX, VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Stifel Downgrades Vigil Neuroscience to Hold, Lowers Price Target to $8
Stifel analyst Paul Matteis downgrades Vigil Neuroscience from Buy to Hold and lowers the price target from $11 to $8.
HC Wainwright & Co. Downgrades Vigil Neuroscience to Neutral, Lowers Price Target to $8
HC Wainwright & Co. analyst Andrew Fein downgrades Vigil Neuroscience from Buy to Neutral and lowers the price target from $14 to $8.
Acciones Relacionadas
DECAU
Denali Capital Acquisition Corp. Unit
TWI
Titan International Inc. (DE)
FAM
First Trust/abrdn Global Opportunity Income Fund Common Shares of Beneficial Interest
SGLY
Singularity Future Technology Ltd.
KNX
Knight-Swift Transportation Holdings Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.